background
distinguish
myometri
invas
adenomyosi
involv
import
stage
endometri
endometrioid
adenocarcinoma
aim
compar
limit
valu
scenario
interferoninduc
transmembran
protein
recent
describ
sensit
specif
marker
endometri
stroma
review
hysterectomi
contain
endometri
endometrioid
adenocarcinoma
adenomyosi
tumor
area
classifi
unequivoc
myoinvas
unequivoc
noninvas
foci
equivoc
invas
also
record
immunohistochemistri
perform
score
term
intens
distribut
classifi
neg
posit
imag
cont
c
immunohistochemistri
interferoninduc
transmembran
protein
neg
around
myoinvas
carcinoma
show
express
stroma
endometrium
adenomyosi
e
f
immunohistochemistri
show
strong
diffus
stain
around
invas
noninvas
carcinoma
ajcp
origin
articl
imag
cont
e
f
strongli
diffus
express
peritumor
mesenchyma
imag
endometri
adenocarcinoma
endometrioid
type
extend
adenomyosi
scan
c
e
b
f
view
b
despit
subtl
irregular
contour
neoplast
popul
residu
normal
endometri
gland
stroma
identifi
peripheri
h
e
ajcp
origin
articl
imag
endometri
adenocarcinoma
endometrioid
type
extend
adenomyosi
c
e
b
f
view
b
residu
normal
endometri
gland
stroma
identifi
peripheri
neoplast
gland
h
e
c
diffus
cytoplasm
interferoninduc
transmembran
protein
express
endometri
stroma
ajcp
origin
articl
result
unlik
stain
show
signific
differ
mean
intens
p
distribut
p
invas
vs
noninvas
area
sixteen
invas
noninvas
area
posit
p
contrast
none
invas
vs
noninvas
area
posit
p
sensit
specif
detect
stroma
surround
endometrioid
adenocarcinoma
henc
exclud
myoinvas
eleven
foci
design
equivoc
stain
conclus
compar
superior
perform
distinguish
endometri
stroma
adenomyosi
mesenchyma
surround
invas
endometri
adenocarcinoma
express
highli
predict
absenc
invas
may
valuabl
case
determin
myoinvas
stage
implic
determin
depth
invas
endometri
adenocarcinoma
therapeut
prognost
implic
import
stage
purpos
one
pitfal
encount
assess
depth
invas
differenti
myometri
invas
involv
adenomyosi
especi
involv
adenomyosi
foci
locat
outer
myometrium
tumor
extens
adenomyosi
encount
hysterectomi
specimen
endometri
endometrioid
adenocarcinoma
phenomenon
howev
affect
prognosi
implic
patholog
stage
unfortun
distinct
adenomyosi
true
myometri
invas
frequent
challeng
interobserv
variabl
differenti
high
common
acut
lymphoblast
leukemia
antigen
sensit
marker
endometri
stromal
cell
upon
complet
activ
abl
outlin
clinic
stage
implic
differenti
myometri
invas
endometri
adenocarcinoma
extens
adenomyosi
list
differ
sensit
specif
marker
endometri
stroma
set
describ
expect
stain
pattern
stroma
adenomyosi
compar
pattern
associ
myometri
invas
adenocarcinoma
endometrium
ascp
accredit
accredit
council
continu
medic
educ
provid
continu
medic
educ
physician
ascp
design
journalbas
cme
activ
maximum
ama
pra
categori
credit
tm
per
articl
physician
claim
credit
commensur
extent
particip
activ
activ
qualifi
american
board
patholog
mainten
certif
part
ii
selfassess
modul
author
articl
plan
committe
member
staff
relev
financi
relationship
commerci
interest
disclos
exam
locat
wwwascporgajcpcm
previous
hypothes
would
stain
endometri
stroma
surround
foci
adenomyosi
absent
myoinvas
area
howev
independ
studi
disprov
hypothesi
show
frequent
express
myometrium
surround
frankli
invas
endometri
carcinoma
interferoninduc
transmembran
protein
also
known
recent
describ
novel
marker
endometri
stromal
differenti
express
uteru
restrict
endometri
stroma
stain
diffus
strong
stromal
cell
well
weak
absent
endometri
gland
myometrium
human
mous
sampl
moreov
express
consist
higher
endometri
stromal
neoplasm
compar
smooth
muscl
tumor
suggest
potenti
use
marker
endometri
stroma
clinic
practic
studi
sought
evalu
abil
differenti
true
myometri
invas
endometri
endometrioid
adenocarcinoma
involv
adenomyosi
also
compar
perform
diagnost
scenario
last
appli
marker
area
deem
equivoc
myometri
invas
routin
histopatholog
analysi
studi
approv
ottawa
health
scienc
research
ethic
board
retriev
h
estain
glass
slide
consecut
case
endometri
adenocarcinoma
endometrioid
type
uteri
contain
adenomyosi
two
repres
slide
contain
frank
myometri
invas
andor
tumor
adenomyosi
select
case
addit
age
diagnosi
intern
feder
gynecolog
obstetr
figo
tumor
grade
depth
invas
myometri
thick
note
final
surgic
patholog
report
materi
review
two
gynecolog
pathologist
cph
bd
patholog
resid
ab
area
interest
mark
slide
number
area
interest
rang
two
three
case
area
classifi
follow
unequivoc
myometri
invas
invas
myoinvas
confirm
pathologist
form
pushingexpansil
andor
frankli
destruct
singl
cell
angul
gland
desmoplast
stroma
infiltr
unequivoc
adenomyosi
involv
adenocarcinoma
noninvas
adenomyosi
involv
confirm
pathologist
area
tumor
welldefin
contour
least
focal
surround
nonneoplast
endometri
gland
andor
stroma
equivoc
invas
group
compris
area
disagr
two
pathologist
regard
myoinvas
area
one
pathologist
felt
uncertain
presenc
myoinvas
slide
select
paraffinembed
tissu
materi
stain
mesenchyma
surround
adenocarcinoma
gland
score
follow
intens
absent
stain
weak
stain
moder
stain
strong
stain
distribut
absent
stain
less
focu
circumfer
circumfer
circumfer
total
score
calcul
ad
intens
distribut
score
area
rang
group
purpos
total
score
consid
neg
total
score
classifi
posit
statist
analys
perform
use
graphpad
prism
version
window
graphpad
softwar
la
jolla
ca
unpair
twotail
student
test
use
compar
mean
score
correspond
area
unequivoc
myoinvas
area
unequivoc
adenomyosi
involv
adenocarcinoma
intens
distribut
total
score
analyz
separ
follow
convers
total
score
categor
data
neg
posit
correl
posit
presenc
myoinvas
assess
use
v
test
p
valu
less
consid
statist
signific
clinic
characterist
studi
popul
summar
tabl
mean
age
time
surgeri
year
rang
year
patient
endometrioid
adenocarcinoma
endometrioid
type
figo
grade
nine
figo
grade
myometri
invas
document
case
figo
stage
four
stage
three
addit
case
contain
extens
adenocarcinoma
adenomyosi
definit
myometri
invas
total
area
adenocarcinoma
myometrium
identifi
select
immunohistochem
analysi
independ
assess
materi
consensu
diagnosi
area
classifi
follow
foci
unequivoc
myometri
invas
foci
unequivoc
adenomyosi
involv
adenocarcinoma
noninvas
foci
equivoc
invas
exampl
area
test
well
immunohistochem
stain
pattern
depict
imag
imag
imag
imag
well
tabl
tabl
show
similar
stain
intens
invas
mean
score
noninvas
area
mean
score
p
interestingli
distribut
stain
show
differ
patchi
invas
foci
mean
score
diffus
noninvas
foci
mean
score
p
result
differ
total
score
two
group
statist
signific
invas
vs
noninvas
area
p
howev
classifi
total
score
posit
neg
statist
differ
stain
group
invas
area
noninvas
area
posit
p
result
excel
sensit
poor
specif
limit
diagnost
accuraci
detect
endometri
stroma
exclud
myometri
invas
contrast
express
significantli
differ
group
stain
vs
mean
intens
p
vs
distribut
p
vs
total
score
invas
vs
noninvas
area
respect
p
classifi
posit
neg
stain
neg
invas
area
posit
noninvas
area
word
area
express
noninvas
wherea
area
neg
invas
p
thu
sensit
specif
posit
predict
valu
neg
predict
valu
detect
stroma
surround
endometrioid
adenocarcinoma
henc
exclud
myoinvas
diagnost
accuraci
superior
identifi
foci
consid
equivoc
myometri
invas
previous
describ
stain
characterist
area
depict
tabl
imag
area
posit
mean
total
score
intens
distribut
hand
equivoc
area
posit
mean
total
score
intens
distribut
base
previous
calcul
specif
posit
predict
valu
express
presenc
stain
allow
exclud
myoinvas
area
diagnost
disagr
uncertainti
diagnosi
myometri
invas
endometri
adenocarcinoma
common
challeng
examin
hysterectomi
specimen
endomyometri
interfac
routin
section
commonli
irregular
convolut
addit
adenocarcinoma
extend
area
adenomyosi
may
mimic
myometri
invas
case
area
concern
invas
locat
inner
myometrium
therefor
uncertainti
interpret
carri
advers
consequ
stage
clinic
manag
per
current
clinic
guidelin
less
frequent
suspici
area
locat
outer
myometrium
interpret
invas
vs
noninvas
affect
stage
becom
clinic
relev
diagnost
reproduc
myometri
invas
endometri
adenocarcinoma
good
obvious
infiltr
destruct
pattern
invas
present
hand
expansil
push
invas
myometri
wall
often
repres
sourc
difficulti
disagr
among
pathologist
fact
discrep
andor
uncertainti
interpret
myometri
invas
observ
much
area
analyz
studi
demonstr
residu
nonneoplast
endometri
gland
andor
stroma
suspici
area
confirm
adenomyosi
therefor
exclud
myoinvas
howev
endometri
stroma
adenomyosi
commonli
attenu
fibrot
appear
routin
h
e
prepar
wide
use
immunohistochem
marker
endometri
stroma
limit
valu
scenario
consist
express
area
adenomyosi
involv
tumor
also
highlight
reactivedesmoplast
mesenchym
cell
surround
myoinvas
adenocarcinoma
well
lymphocyt
therefor
commonli
posit
imag
myoinvas
endometri
adenocarcinoma
endometrioid
type
background
adenomyosi
c
e
b
f
view
b
neoplast
gland
irregular
distribut
invad
myometrium
h
e
c
absenc
interferoninduc
transmembran
protein
express
mesenchyma
surround
adenocarcinoma
endothelium
interspers
capillari
posit
serv
intern
posit
control
area
myometri
invas
result
low
specif
attent
distribut
stain
around
suspici
focu
may
valu
sinc
tend
diffus
circumferenti
adenomyosi
patchi
myoinvas
diagnost
purpos
absenc
stain
strong
indic
myometri
invas
howev
scenario
rather
infrequ
previou
report
studi
thu
specif
marker
endometri
stromal
differenti
need
initi
identifi
respons
interferon
stimul
neuroblastoma
cell
line
ifitm
famili
inhibit
multipl
pathogen
virus
mainli
restrict
viral
fusion
cell
membran
earli
phase
infect
addit
antivir
properti
ifitm
gene
express
also
involv
develop
silenc
embryogenesi
disrupt
establish
posterior
axi
also
known
mediat
antiprolif
growthinhibitori
effect
interferon
c
although
function
human
femal
genit
tract
fulli
understood
yet
studi
suggest
role
uterin
growth
embryo
implant
part
wntbcatenin
signal
pathway
recent
character
sensit
specif
marker
endometri
stromal
differenti
situ
hybrid
studi
shown
messeng
rna
level
mainli
express
endometri
stromal
cell
mice
immunohistochemistri
consist
express
endometri
stroma
normal
endometrium
independ
hormon
statu
activ
vs
inact
endometrium
menstrual
cycl
phase
prolif
vs
secretori
well
stroma
adenomyosi
express
immunohistochemistri
also
demonstr
endometri
stromal
neoplasm
includ
endometri
stromal
nodul
lowgrad
endometri
stromal
sarcoma
given
high
specif
endometri
stroma
may
valuabl
scenario
requir
demonstr
endometri
stroma
diagnosi
endometriosi
knowledg
studi
first
explor
ancillari
immunohistochem
test
diagnosi
myometri
invas
adenocarcinoma
recommend
use
demonstr
immunohistochemistri
use
scenario
superior
specif
marker
endometri
stroma
sinc
neg
definit
myoinvas
area
presenc
stain
virtual
confirm
adenomyosi
exclud
myometri
invas
base
data
posit
would
help
imag
cont
c
interferoninduc
transmembran
protein
immunohistochemistri
strongli
diffus
posit
endometri
stroma
around
adenocarcinoma
e
f
similar
pattern
observ
classifi
noninvas
area
diagnost
uncertainti
disagr
practic
result
indic
immunohistochemistri
potenti
prevent
overinterpret
myometri
invas
incorrect
upstag
hand
neg
result
also
seen
definit
adenomyosi
thu
result
entir
confirm
myoinvas
import
note
adenomyosi
involv
tumor
may
complet
devoid
stroma
stromapoor
adenomyosi
case
distinct
true
myometri
invas
reli
sole
morpholog
examin
diagnosi
myometri
invas
aris
deep
adenomyosi
challeng
particularli
carcinoma
present
adenomyosi
absent
endometri
surfac
rare
welldocu
phenomenon
care
microscop
examin
help
invas
consid
contour
irregular
fingerlik
frankli
infiltr
gland
aris
welldemarc
glandular
area
addit
attent
distribut
stain
may
prove
use
studi
area
identifi
adenomyosi
show
stain
area
circumfer
score
mean
distribut
score
convers
distribut
score
myoinvas
area
mean
express
rang
absent
less
focu
circumfer
thu
focu
adenomyosi
contour
irregular
stain
diffus
smooth
noninvas
part
focu
circumfer
convers
patchi
absent
irregular
invas
part
given
rariti
diagnost
challeng
scenario
studi
explor
hypothes
requir
summari
demonstr
marker
endometri
stroma
valu
determin
myometri
invas
endometri
adenocarcinoma
hysterectomi
contain
adenomyosi
marker
excel
specif
posit
predict
valu
presenc
around
suspici
foci
adenocarcinoma
virtual
exclud
myoinvas
potenti
aid
workup
case
diagnosi
myoinvas
stage
implic
valid
find
subsequ
studi
necessari
correspond
author
carlo
parraherran
md
fcap
univers
toronto
sunnybrook
health
scienc
centr
imag
cont
e
f
similar
pattern
observ
